Walleye Capital’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.6M | Buy |
|
|||||
|
2025
Q1 | $1.16M | Sell |
|
|||||
|
2024
Q4 | $2.7M | Buy |
|
|||||
|
2024
Q3 | $1.97M | Buy |
|
|||||
|
2024
Q2 | $1.29M | Buy |
|
|||||
|
2024
Q1 | $324K | Sell |
|
|||||
|
2023
Q4 | $4.28M | Buy |
|
|||||
|
2023
Q3 | $5.03M | Buy |
|
|||||
|
2023
Q2 | $1.24M | Buy |
|
|||||
|
2023
Q1 | $79.6K | Sell |
|
|||||
|
2022
Q4 | $6.95M | Buy |
|
|||||
|
2022
Q3 | $3.04M | Buy |
|
|||||
|
2022
Q2 | $631K | Sell |
|
|||||
|
2022
Q1 | $2.97M | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $591 | Buy |
|
|||||
|
2021
Q2 | $221 | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $313K | Buy |
|
|||||
|
2019
Q4 | $357K | Buy |
|